Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
layoffs
Biotech
Gilead pays $43.5M for Xilio's early-phase IL-12 prospect
Gilead is bucking the trend in IL-12, entering the space after seeing rivals such as AstraZeneca and Bristol Myers Squibb retreat from the cytokine.
Nick Paul Taylor
Mar 28, 2024 8:08am
Fierce Biotech Layoff Tracker '24: Bayer, BMS & more
Mar 27, 2024 11:10am
Theratechnologies sheds preclinical oncology research programs
Mar 25, 2024 5:30am
After $2B acquisition, GSK sends some Bellus workers packing
Mar 22, 2024 11:08am
Siemens Healthineers to close down Fast Track PCR testing unit
Mar 19, 2024 10:02am
Spruce lays off 5th of staff in wake of phase 2 hyperplasia fail
Mar 14, 2024 8:27am